Veranex Acquires Leading Preclinical Services Provider T3 Labs

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Veranex-Solutions

More Like This

Veranex launches Innovation CRO for device and diagnostics.

Veranex Unveils MedTech’s First Innovation CRO (iCRO)—Redefining R&D in a Capital‑Tight Market

Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma

Vironova BioAnalytics AB Acquired by an investor syndicate, led by Quatre Lab, to expand its TEM services for the pharmaceutical industry; to be rebranded as QuTEM

Ardena Expands Bioanalytical Services in Europe

Avance Clinical Announces Senior Appointment to North American Operations

Myonex to Acquire Creapharm’s Clinical & Commercial Packaging and Bioservices Business

PR Newswire associated0

MYONEX CLOSES CREAPHARM ACQUISITION EXPANDING GLOBAL SERVICES

Avance Clinical GlobalReady Site Partnership Network Expands Rapidly to 2,000 Site Members